Increased tendency to bruise
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Short neck
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Kyphoscoliosis deformity of spine
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Redundant skin
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Redundant skin
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital exomphalos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Prominent superficial veins
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Squared iliac bones
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Range of joint movement increased
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Poor wound healing
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Low posterior hairline
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Prematurely aged appearance
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Thoracic scoliosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bilateral ptosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atypical scarring of skin
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Structural foot deformity
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Thin eyebrow
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ehlers-Danlos Syndrome
|
0.030 |
Biomarker
|
disease |
BEFREE |
This report further expands the clinical, molecular and ultrastructural spectrum associated with AEBP1 defects and highlights the complex and variable phenotype associated with this new EDS variant.
|
30668708 |
2019 |
Ehlers-Danlos Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Biallelic variants in the AEBP1 gene cause a novel autosomal-recessive connective tissue disorder (CTD) reminiscent of Ehlers-Danlos Syndrome (EDS).
|
30548383 |
2019 |
Neoplasm Metastasis
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
IHC revealed that the expression of AEBP1 in CRC tissues was significantly higher than that in adjacent healthy tissues, and that it is associated with Tumor-Node-Metastasis stage, recurrence and metastasis.
|
30655737 |
2019 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
|
31219650 |
2019 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
IHC revealed that the expression of AEBP1 in CRC tissues was significantly higher than that in adjacent healthy tissues, and that it is associated with Tumor-Node-Metastasis stage, recurrence and metastasis.
|
30655737 |
2019 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
We observed that AEBP1 was overexpressed in COAD tissues and cells and that the expression of AEBP1 was correlated with tumor size, the level of histologic differentiation, lymph node metastasis, and cancer stage in COAD patients.
|
31219650 |
2019 |
Fatty Liver Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
AEBP1 knockdown resulted in decreased expression of nine genes previously identified to be part of a predicted AEBP1-associated NASH co-regulatory network and confirmed to be upregulated in fibrotic tissue.
|
31299062 |
2019 |
Ehlers-Danlos Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
These studies support the conclusion that bi-allelic pathogenic variants in AEBP1 are the cause of this autosomal-recessive EDS subtype.
|
29606302 |
2018 |